Company / Capital Expenditures
ORTHOPEDIATRICS CORP Capital Expenditures History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$16.9M
FY2025
5-year range
$8.1M / $16.9M
FY2021-FY2025
Trend
+68.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $8M to $17M over the past 2 years.
Based on SEC 10-K filings.
$17M in FY2025 with a 5-year CAGR of +26.3%.
Improved from $8M to $17M over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +17.1%
- 5-Year CAGR
- +26.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +26.3%, indicating consistent growth.
- In FY2025, capital expenditures increased 68.3% year-over-year.
- Lowest capital expenditures in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.9M | +68.3% |
| FY2024 | $10.0M | +23.8% |
| FY2023 | $8.1M | -22.9% |
| FY2022 | $10.5M | -11.1% |
| FY2021 | $11.8M | +124.9% |
| FY2020 | $5.3M | +0.9% |
| FY2019 | $5.2M | +19.8% |
| FY2018 | $4.3M | +96.7% |
| FY2017 | $2.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026